Timothy Olsen, MD, Ophthalmology, Rochester, MN, Mayo Clinic Hospital - Rochester

TimothyWOlsenMDProfessor of Ophthalmology

Ophthalmology Rochester, MN

Retinal Disease

Professor of Ophthalmology, Consultant, Mayo Clinic

Dr. Olsen is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Olsen's full profile

Already have an account?

Summary

  • Dr. Timothy Olsen is an ophthalmologist at the Mayo Clinic - Rochester Rochester, MN and Chair Emeritus at Emory University Hospital. He received his medical degree from University of Kansas School of Medicine and has been in practice 28 years. He specializes in retinal disease and is experienced in age-related macular degeneration, intraocular tumors, vitreoretinal disease, pediatric retinal disease, and pigment epithelium disorders in the eye.

Skills & Expertise

  • Pigment Epithelium of Eye, Macular degeneration, Vitreoretinal disease, Surgery, Intraocular tumors

Education & Training

  • Emory UniversityFellowship, Vitreoretinal Surgery, 1993 - 1996
  • University of MinnesotaResidency, Ophthalmology, 1991 - 1993
  • St Luke's HospitalInternship, Internal Medicine, 1989 - 1990
  • University of Kansas School of MedicineClass of 1989
  • University of KansasB.A., Human Biology, Summa Cum Laude, 1981 - 1985

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2017 - 2022
  • IL State Medical License
    IL State Medical License 1995 - 1999
  • WI State Medical License
    WI State Medical License 1995 - 2001
  • GA State Medical License
    GA State Medical License 1994 - 2017
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Charter Inductee Retina Hall of Fame RHOF, 2017
  • Research and Innovation Award Lions Eye Institute for Transplantation and Research, Tampa Bay FL, 2015
  • Love of Sight Visionary Award FFB, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • In cases of symptomatic vitreomacular adhesion without full-thickness macular hole, do you tend to observe for spontaneous resolution or treat with jetrea (ocriplasmin...  
    Tornambe PE, Singer M, Olsen TW, London N, Ocular Surgery News, 10/1/2014
  • Chorioretinal folds: associated disorders and a related maculopathy  
    Olsen TW,Palejwala NV, Lee LB, Bergstrom CS, Yeh S, Am J Ophthalmol, 5/1/2014
  • Effect of Long-Chain omega-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Random...  
    Writing Group for the ARG, Bonds DE, Harrington M, et al, JAMA Internal Medicine, 3/17/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Global Burden of Diabetic Retinopathy and Age-Related Macular Degeneration.
    Olsen TW, Global Vision Course, Rollins School of Public Health., 5/5/2014
  • Correlation between Visual Acuity and Spectral Domain Optical Coherence Tomography Findings in Birdshot Choriortinopathy Patients.
    Ho VY, Shantha FF, Forooghian C, Bergstrom C, Hubbard GB, Olsen TW, Patel P, Yeh S, ARVO, Seattle, WA, 5/8/2013
  • Macular Diseases other than AMD.
    Olsen TW, ARVO, Seattle, WA, 5/7/2013
  • Join now to see all

Lectures

  • Macular Surgery and Complications. 
    Orlando, FL - 10/20/2014
  • Future Treatments for AMD. 
    Chicago, IL - 10/19/2014
  • Suprachoroidal, Trans-scleral, and Microneedle Drug Delivery. 
    Chicago, IL - 10/19/2014
  • Join now to see all

Other

  • Consultants for Focal Points (Clinical Modules for Ophthalmologists); Pharmacotherapy Targeting Ocular Neovascularization (Comments to issues raised in the Review). 
    Olsen TW, Hartnett ME, American Academy of Ophthalmology
    9/1/2008

Press Mentions

  • Seeing Dramatic Results After a Frightening Eye Injury
    Seeing Dramatic Results After a Frightening Eye InjuryJune 14th, 2019
  • Business Innovation with an Eye on Improving Vision
    Business Innovation with an Eye on Improving VisionMarch 13th, 2019
  • IOL Selection Important in Patients with Retinal Disease
    IOL Selection Important in Patients with Retinal DiseaseJuly 18th, 2017
  • Join now to see all

Grant Support

  • Intraocular Aerosol Treatment for inhibition of Proliferative VitreoretinopathyNIH/NEI2014–Present
  • Age-Related Macular Degeneration: Choroidal Translocation Surgery in the Primate ModelAbraham J. and Phyllis Katz Foundation2013–Present
  • RO1EY022097NIH/NEI2013–Present
  • Age-Related Macular Degneration Grant: Choroidal Translocation Surgery in the Primate ModelR. Howard Dobbs Jr. Foundation2012–Present
  • A Tissue Support Structure (Macular O-Rings) for Reconstructing, Translocating, or Transplanting Three-Dimensional Submacular Tissue Organoids in Age Related Macular Degeneration (AMD)NIH/NEI2019–2020
  • Age-Related Macular Degeneration: Choroidal Translocation Surgery in the Primate Model.The Fraser Parker Foundation2012–2013
  • The Subproteome In Age-Related Macular DegenerationNational Institute On Aging2007–2008
  • The Subproteome In Age-Related Macular DegenerationNational Institute On Aging2004–2007

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Manager, iMacular Regeneration LLCStart-Up CompanyDisclosure: Minimal Financial Value (11-2016)2016 - Present